rs4545

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000498.3(CYP11B2):​c.1303G>A​(p.Gly435Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0461 in 1,614,188 control chromosomes in the GnomAD database, including 8,072 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. G435G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.054 ( 875 hom., cov: 32)
Exomes 𝑓: 0.045 ( 7197 hom. )

Consequence

CYP11B2
NM_000498.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.72

Publications

37 publications found
Variant links:
Genes affected
CYP11B2 (HGNC:2592): (cytochrome P450 family 11 subfamily B member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane. The enzyme has steroid 18-hydroxylase activity to synthesize aldosterone and 18-oxocortisol as well as steroid 11 beta-hydroxylase activity. Mutations in this gene cause corticosterone methyl oxidase deficiency. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000498.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.875816E-5).
BP6
Variant 8-142912625-C-T is Benign according to our data. Variant chr8-142912625-C-T is described in ClinVar as Benign. ClinVar VariationId is 362192.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.481 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000498.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP11B2
NM_000498.3
MANE Select
c.1303G>Ap.Gly435Ser
missense
Exon 8 of 9NP_000489.3P19099

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP11B2
ENST00000323110.2
TSL:1 MANE Select
c.1303G>Ap.Gly435Ser
missense
Exon 8 of 9ENSP00000325822.2P19099
CYP11B2
ENST00000945895.1
c.1372G>Ap.Gly458Ser
missense
Exon 8 of 9ENSP00000615954.1
CYP11B2
ENST00000945896.1
c.1291G>Ap.Gly431Ser
missense
Exon 8 of 9ENSP00000615955.1

Frequencies

GnomAD3 genomes
AF:
0.0541
AC:
8233
AN:
152182
Hom.:
871
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0275
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.109
Gnomad ASJ
AF:
0.0369
Gnomad EAS
AF:
0.496
Gnomad SAS
AF:
0.156
Gnomad FIN
AF:
0.0493
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0196
Gnomad OTH
AF:
0.0574
GnomAD2 exomes
AF:
0.0918
AC:
23095
AN:
251444
AF XY:
0.0892
show subpopulations
Gnomad AFR exome
AF:
0.0271
Gnomad AMR exome
AF:
0.139
Gnomad ASJ exome
AF:
0.0333
Gnomad EAS exome
AF:
0.505
Gnomad FIN exome
AF:
0.0529
Gnomad NFE exome
AF:
0.0192
Gnomad OTH exome
AF:
0.0626
GnomAD4 exome
AF:
0.0453
AC:
66194
AN:
1461886
Hom.:
7197
Cov.:
40
AF XY:
0.0478
AC XY:
34750
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0230
AC:
770
AN:
33480
American (AMR)
AF:
0.133
AC:
5952
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0321
AC:
838
AN:
26136
East Asian (EAS)
AF:
0.503
AC:
19976
AN:
39700
South Asian (SAS)
AF:
0.146
AC:
12573
AN:
86258
European-Finnish (FIN)
AF:
0.0508
AC:
2716
AN:
53420
Middle Eastern (MID)
AF:
0.0324
AC:
187
AN:
5768
European-Non Finnish (NFE)
AF:
0.0176
AC:
19622
AN:
1112006
Other (OTH)
AF:
0.0589
AC:
3560
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
4115
8231
12346
16462
20577
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1108
2216
3324
4432
5540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0542
AC:
8251
AN:
152302
Hom.:
875
Cov.:
32
AF XY:
0.0614
AC XY:
4572
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0275
AC:
1143
AN:
41576
American (AMR)
AF:
0.109
AC:
1674
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0369
AC:
128
AN:
3472
East Asian (EAS)
AF:
0.497
AC:
2561
AN:
5156
South Asian (SAS)
AF:
0.156
AC:
754
AN:
4830
European-Finnish (FIN)
AF:
0.0493
AC:
524
AN:
10622
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0197
AC:
1337
AN:
68026
Other (OTH)
AF:
0.0587
AC:
124
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
345
690
1036
1381
1726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0353
Hom.:
1371
Bravo
AF:
0.0561
Asia WGS
AF:
0.273
AC:
948
AN:
3478
EpiCase
AF:
0.0147
EpiControl
AF:
0.0160

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Corticosterone 18-monooxygenase deficiency (2)
-
-
2
Corticosterone methyloxidase type 2 deficiency (2)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Corticosterone methyl oxidase type II deficiency (1)
-
-
1
Glucocorticoid-remediable aldosteronism (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.97
DANN
Benign
0.76
DEOGEN2
Benign
0.081
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.014
N
LIST_S2
Benign
0.60
T
MetaRNN
Benign
0.000099
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.23
N
PhyloP100
-1.7
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.65
N
REVEL
Benign
0.18
Sift
Benign
0.43
T
Sift4G
Benign
0.56
T
Varity_R
0.089
gMVP
0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4545;
hg19: chr8-143994041;
COSMIC: COSV59995205;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.